McEvory JP, Scheifler PL, Frances A (1999) The expert consensus guidelines series: treatment of schizophrenia. J Clin Psychiatry 60:4–80
Google Scholar
Davis PB, Yee RL, Millar J (1994) Accounting for medical variation: the case of prescribing activity in a New Zealand general practice sample. Soc Sci Med 39:367–374
Article
CAS
PubMed
Google Scholar
Park S-C, Lee M-S, Kang S-G, Lee S-H (2014) Patterns of antipsychotic prescription to patients with schizophrenia in Korea: results from the Health Insurance Review & Assessment Service-National Patient Sample. J Korean Med Sci 29(5):719–728
Article
PubMed
PubMed Central
Google Scholar
Chen RS, Nadkarni PM, Levin FL, Miller PL, Erdos J, Rosenheck RA (2000) Using a computer database to monitor compliance with pharmacotherapeutic guidelines for Schizophrenia. Psychiatr Serv 51:791–794
Article
CAS
PubMed
Google Scholar
Owen RR, Thrush CR, Kirchner JE, Booth BM (2000) Performance measurement for schizophrenia: adherence to guidelines for antipsychotic dose. Int J Qual Health Care 12:475–482
Article
CAS
PubMed
Google Scholar
Lehman AF, Steinwachs DM (1998) Pattern of usual care for schizophrenia: initial results from the Schizophrenia Patient outcomes Research Team (PORT) client survey. Schizophr Bull 24:11–20
Article
CAS
PubMed
Google Scholar
Young AS, Sullivan G, Burnam MA, Brook RH (1998) Measuring the quality of outpatient treatment for Schizophrenia. Arch Gen Psychiatry 55:611–617
Article
CAS
PubMed
Google Scholar
Clark RE, Bartels SJ, Mellman TA, Peacock WJ (2002) Recent trends in antipsychotic combination therapy of schizophrenia and schizoaffective disorder: implications for State mental health policy. Schizophr Bull 28(l):75 -84, 2002
Article
PubMed
Google Scholar
Covell NH, Jackson CT, Evans AC, Essock SM (2002) Antipsychotic prescribing practices in Connecticut’s public mental health system: rates of changing medications and prescribing styles. Schizophr Bull 28(1):17–29
Article
PubMed
Google Scholar
Pappadopulos E, Jensen PS, Schur SB, Rube D (2002) “Real world” atypical antipsychotic prescribing practices in public child and adolescent inpatient settings. Schizophr Bull 28(1):111–121
Article
PubMed
Google Scholar
Weissman E (2002) Antipsychotic prescribing practices in the Veterans Healthcare Administration-New York metropolitan region. Schizophr Bull 28(l):31–42
Article
PubMed
Google Scholar
Howes OD, Vergunst F, Gee S, Mc Guire P, Kapur S, Taylor D (2012) Adherence to treatment guidelines in clinical practice: study of antipsychotic treatment prior to clozapine initiation. Br J Psychiatry 201:481–485
Article
PubMed
Google Scholar
Paton C, Lelliott P, Harrington M, Okacha C, Sensky T, Duffet R (2003) Patterns of antipsychotics and anticholinergic prescribing for hospital inpatient. J Psychopharmacol 17(2):223–229
Article
PubMed
Google Scholar
Olajide A, Mansfield M, Olubankole O, Udoka O (2016) Psychotropic drug prescription practice in psychiatric inpatients in Saskatchewan, Canada. J Neuropsychopharmacol Mental Health 1(4):114
Article
Google Scholar
Ghosh S, Bhattacharyya S, Dalai CK (2013) Antipsychotic prescribing pattern in a tertiary Care Hospital Of Eastern India. J Drug Deliv Ther 3(4):38–42
Google Scholar
Amr M, Amin T, Al-Rhaddad D et al (2013) Antipsychotic prescribing pattern in Arab patients with schizophrenia. Eur Psychiatry 28(1):1
Article
Google Scholar
Khaja K, Al-Haddad M, Sequeira R, Al-Offi AR (2012) Antipsychotic and anticholinergic drug prescribing pattern in psychiatry: extent of evidence-based practice in Bahrain. Pharmacol Pharm 3(4):409–416
Article
Google Scholar
Peralta V, Cuesta MJ, Caro F, Martinez-Larrea A (1994) Neuroleptic dose and schizophrenic symptoms. A survey of prescribing practices. Acta Psychiatr Scand 90(5):354–357
Article
CAS
PubMed
Google Scholar
Cuffel BJ, Fischer EP, Owen RR Jr, Smith GR Jr (1997) An instrument for measurement of outcomes of care for schizophrenia. Issues in development and implementation. Eval Health Prof 20(1):96–108
Article
CAS
PubMed
Google Scholar
Essock SM (2002) Antipsychotic prescribing practices. Schizophr Bull 28(1):1–4
Article
PubMed
Google Scholar
Mukesh R, Mohanta GP, Lokesh U (2010) Study of prescription practice for antipsychotic drugs by psychiatrists- a survey. Indian J Pharmacol Pract 3(2):23–27
Google Scholar
Baandrup L, Gasse C, Jensen VD, Glenthoj BY, Nordentojlt M, Lublin H (2010) Antipsychotic polypharmacy and risk of death from natural causes in patients with schizophrenia: a population-based nested case-control study. J Clin Psychiatry 71(2):103–108
Article
PubMed
Google Scholar
Latas M, Stojkovic T, Ralic T, Millovanovic S, Jasovic-Gasic M (2012) Psychiatrists Psychotropic Drug Prescription Preferences for themselves or their family members. Psychiatr Danub 24(2):182–187
CAS
PubMed
Google Scholar
Alkhadhari S, Al Zain N, Darwish T, Khan S, Okasha T, Ramy H (2015) Use of second-generation antipsychotics in the acute inpatient management of schizophrenia in the Middle East. Neuropsychiatr Dis Treat 11:915–924
CAS
PubMed
PubMed Central
Google Scholar
Kissling W (1994) Compliance, quality assurance and standards for relapse prevention in schizophrenia. Acta Psychiatr Scand Suppl 382:16–24
Article
CAS
PubMed
Google Scholar
Day JC, Bentall RP, Roberts C, Randall F, Rogers A, Catell D (2005) Attitudes toward antipsychotic medication: the impact of clinical variables and relationships with health professionals. Arch Gen Psychiatry 62(7):717–724
Article
PubMed
Google Scholar
El-Gabry DM, Abdel Aziz K, Okasha T, Azzam H, Okasha A (2018) Antipsychotic polypharmacy and its relation to metabolic syndrome in patients with schizophrenia: an Egyptian Study. J Clin Psychopharmacol 38(1):27–33
Article
Google Scholar
El-Gabry DM, Ghanem M, Okasha T, Azzam H, Okasha A. Antipsychotic polypharmacy versus monotherpy and its metabolic side effects [M.D. Thesis]. Faculty of Medicine, Ain Shams University; 2013.
Loza N, Sorour E (2016) Brain drain: the issues raised for Egypt by the emigration of psychiatrists. B J Psych Int 13(3):59–61
CAS
Google Scholar
Kendall T (2011) The rise and fall of the atypical antipsychotics. Br J Psychiatry 199(4):266–268
Article
PubMed
Google Scholar
Geddes J, Freemantle N, Harrison P, Bebbington P (2000) Atypical antipsychotics in the treatment of schizophrenia: systematic overview and meta-regression analysis. Br Med J 321:1371–1376
Article
CAS
Google Scholar
Lieberman JA, Stroup TS, McEvoy JP, Swartz MS, Rosenheck RA, Perkins DO (2005) Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. N Engl J Med 353:1209–1223
Article
CAS
PubMed
Google Scholar
Jones PB, Barnes TRE, Davies L, Dunn G et al (2006) Controlled trial of the effect on quality of life of second- vs first-generation antipsychotic drugs in schizophrenia: Cost Utility of the Latest Antipsychotic drugs in Schizophrenia Study (CUtLASS 1). Arch Gen Psychiatry 63:1079–1087
Article
CAS
PubMed
Google Scholar
National Institute for Clinical Excellence (NICE). Psychosis and schizophrenia in adults: treatment and management, 2014 (available at www.nice.org.uk/guidance/cg178/resources/guidance-psychosis-and-schizophrenia-in-adults-treatment-and-management-pdf, Accessed 19 Mar 2018).
Taylor D, Paton C, Kerwin R (2015) The Maudsley Prescribing Guidelines 12th edition. Martin Dunitz, London
Google Scholar
Grover S, Avasthi A (2010) Antipsychotic prescription pattern. A preliminary survey of psychiatrists in India. Indian J Psychiatry 52(3):257–259
Article
PubMed
PubMed Central
Google Scholar
Varghese ST (2007) Antipsychotic drug prescription in postgraduate psychiatry training programs in India: time to reflect. Indian J Psychiatry 49:225
Article
PubMed
PubMed Central
Google Scholar
Haddad PM (2011) Medication cost and antipsychotic prescription. J Pak Psychiatr Soc 8(2):47–49
Google Scholar
Dayalu P, Chou KL (2008) Antipsychotic-induced extrapyramidal symptoms and their management. Expert Opin Pharmacother 9:1451–1462
Article
CAS
PubMed
Google Scholar
Taylor D, Paton C, Kerwin R (2003) The Maudsley Prescribing Guidelines 7th edition. Martin Dunitz, London
Google Scholar
Wu RW (2001) The combination of antipsychotics and anticholinergic medication. Chin Clin Doct 29:33–34
Google Scholar
Xiang YT, Weng YZ, Leung CM, Tang WK, Ungvari GS (2007) Exploring the clinical and social determinants of prescribing anticholinergic medication for Chinese patients with schizophrenia. Hum Psychopharmacol 22:173–180
Article
PubMed
CAS
Google Scholar
Sim K, Su HC, Fujii SY, Tang WK, Ungvari GS (2009) High-dose antipsychotic use in schizophrenia: a comparison between the 2001 and 2004 Research on East Asia Psychotropic Prescription (REAP) Studies. Br J Clin Pharmacol 67(1):110–117
Article
PubMed
PubMed Central
Google Scholar
Seeman P (2002) Atypical antipsychotics: mechanism of action. Can J Psychiatry 47(1):27–38
PubMed
Google Scholar
Wheeler J (2008) Treatment pathway and patterns of clozapine prescribing for schizophrenia in New Zealand. Ann Pharmacother 42(6):852–860
Article
CAS
PubMed
Google Scholar
Gjerden P, Slordal L, Bramness JG (2009) The use of antipsychotic and anticholinergic antiparkinson drugs in Norway after the withdrawal of orphenadrine. Br J Clin Pharmacol 68(2):238–242
Article
CAS
PubMed
PubMed Central
Google Scholar
Hong IS, Bishop JR (2010) Anticholinergic use in children and adolescents after initiation of antipsychotic therapy. Ann Pharmacother 44(7):1171–1180
Article
PubMed
PubMed Central
Google Scholar
Bergman H, Soares-Weiser K (2018) Anticholinergic medication for antipsychotic-induced tardive dyskinesia. Cochrane Database Syst Rev 17(1):CD000204
Google Scholar
Carriere I, Fourrier-Reglat A, Dartigues JF, Tang WK, Ungvari GS (2009) Drugs with anticholinergic properties, cognitive decline, and dementia in an elderly general population: the 3-city study. Arch Intern Med 169(14):1317–1324
Article
CAS
PubMed
PubMed Central
Google Scholar
Cancelli I, Gigli GL, Piani A, Zanchellin B, Janes F, Rinaldi A (2008) Drugs with anticholinergic properties as a risk factor for cognitive impairment in elderly people: a population-based study. J Clin Psychopharmacol 28(6):654–659
Article
PubMed
Google Scholar
Rehse M, Bartolovic M, Baum K, Richter D, Weisbrod M, Roesch-Ely D. Influence of antipsychotic and anticholinergic loads on cognitive functions in patients with schizophrenia. Schizophr Res Treatment 2016; (available at https://www.hindawi.com/journals/schizort/2016/8213165/Accessed 29 Apr 2018).
Land W, Pinsky D, Salzman C (1991) Abuse and misuse of anticholinergic medications. Hosp Community Psychiatry 42:580–581
CAS
PubMed
Google Scholar
Citrome L (2009) Adding lithium or anticonvulsants to antipsychotics for the treatment of schizophrenia: useful strategy or exercise in futility. J Clin Psychiatry 70:932–933
Article
CAS
PubMed
Google Scholar
Luchins DL (1984) Carbamazepine in violent non-epileptic schizophrenics. Psychopharmacol Bull 20:569–571
CAS
PubMed
Google Scholar
Leucht S, Helfer B, Dold M, Kissling W, MC Grath JJ. (2015) Lithium for schizophrenia. Cochrane Database Syst Rev 10:CD003834
Google Scholar
Leucht S, Helfer B, Dold M, Kissling W, McGrath JJ (2014) Carbamazepine for schizophrenia. Cochrane Database Syst Rev 5:CD001258
Google Scholar
Casey DE, Daniel DG, Tamminga C et al (2009) ER combined with olanzapine or risperidone for treatment of acute exacerbations of schizophrenia. Neuropsychopharmacol 34:1330–1338
Article
CAS
Google Scholar